Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Experimental Therapeutics & Oncology
|
December 4, 2003
Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata
Sriram Rajagopal, R Ajaya Kumar, Dhanvanthri S Deevi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy
James R Tonra, Dhanvanthri S Deevi, Erik Corcoran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2007
Tumors established with cell lines selected for oxaliplatin resistance respond to oxaliplatin if combined with cetuximab
Marie Prewett, Dhanvanthri S Deevi, Rajiv Bassi, et al.
Cancer Genomics & Proteomics
|
March 9, 2012
Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC
Selda Samakoglu, Dhanvanthri S Deevi, Huiling Li, et al.
Anticancer Research
|
June 17, 2009
Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models
James R Tonra, Erik Corcoran, Dhanvanthri S Deevi, et al.
Vaccines
|
July 27, 2024
Development of a Cell-Based Reporter Potency Assay for Live Virus Vaccines
Dengyun Sun, Brian K Meyer, Dhanvanthri S Deevi, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 1, 2003
Biological investigation and structure-activity relationship studies on azadirone from Azadirachta indica A. Juss
Srinivas Nanduri, Siva Sanjeeva Rao Thunuguntla, Vijay Kumar Nyavanandi, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2003
Novel 6,7-diphenyl-2,3,8,8a-tetrahydro-1H-indolizin-5-one analogues as cytotoxic agents
Vedula M Sharma, K V Adi Seshu, C Vamsee Krishna, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 26, 2005
N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors
Yong-Jiang Xu, Hua-Quan Miao, Weitao Pan, et al.
Neoplasia (New York, N.Y.)
|
June 2, 2009
Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody
Juqun Shen, Marie Danielle Vil, Marie Prewett, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Experimental Therapeutics & Oncology
|
December 4, 2003
Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata
Sriram Rajagopal, R Ajaya Kumar, Dhanvanthri S Deevi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy
James R Tonra, Dhanvanthri S Deevi, Erik Corcoran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2007
Tumors established with cell lines selected for oxaliplatin resistance respond to oxaliplatin if combined with cetuximab
Marie Prewett, Dhanvanthri S Deevi, Rajiv Bassi, et al.
Cancer Genomics & Proteomics
|
March 9, 2012
Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC
Selda Samakoglu, Dhanvanthri S Deevi, Huiling Li, et al.
Anticancer Research
|
June 17, 2009
Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models
James R Tonra, Erik Corcoran, Dhanvanthri S Deevi, et al.
Vaccines
|
July 27, 2024
Development of a Cell-Based Reporter Potency Assay for Live Virus Vaccines
Dengyun Sun, Brian K Meyer, Dhanvanthri S Deevi, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 1, 2003
Biological investigation and structure-activity relationship studies on azadirone from Azadirachta indica A. Juss
Srinivas Nanduri, Siva Sanjeeva Rao Thunuguntla, Vijay Kumar Nyavanandi, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2003
Novel 6,7-diphenyl-2,3,8,8a-tetrahydro-1H-indolizin-5-one analogues as cytotoxic agents
Vedula M Sharma, K V Adi Seshu, C Vamsee Krishna, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 26, 2005
N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors
Yong-Jiang Xu, Hua-Quan Miao, Weitao Pan, et al.
Neoplasia (New York, N.Y.)
|
June 2, 2009
Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody
Juqun Shen, Marie Danielle Vil, Marie Prewett, et al.
Page
of 2